Proactive Investors - Run By Investors For Investors

Brady chief eyes recovery after root and branch overhaul

Restructuring took its toll on this year's figures but Ian Jenks, Brady Plc's (LON:BRY) executive chairman, tells Proactive that streamlining is complete and the plan now is to grow sales and re-discover the group's tech mojo.
A strong balance sheet will help, as will a rush of consolidation among its rivals.

Meet Alliance Pharma PLC, IXICO PLC, Benchmark Holdings PLC, Clinigen Group PLC and Shield Therapeutics PLC at our event, London , 24 January 2019. Register here »
View full BRY profile View Profile

Brady Plc Timeline

January 25 2018

© Proactive Investors 2018

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use